Veracuity Blog - Veracuity

ACRES and Veracuity Launch COVID-19 Real World Evidence Initiative

UncategorizedBy veracuity April 17, 2020

Veracuity Blog ACRES and Veracuity Launch COVID-19 Real World Evidence Initiative The Alliance for Clinical Research Excellence and Safety (ACRES), a Massachusetts-based global non-profit collaborative, is distributing a simple online tool for collection and analysis of real-world data on predisposing conditions, treatment strategies, outcomes and side effects experienced by COVID-19 patients. This survey tool, designed by Veracuity LLC,…

Details

Benchmarking AI in healthcare

AI in healthcareBy veracuity March 18, 2020

Veracuity Blog Benchmarking AI in healthcare Artificial intelligence (AI) models are becoming an indispensable part of healthcare delivery due to the ever-growing volumes of data the sector produces. The technology supports countless operations, from pattern recognition and classification of disease entities to clinical decision-making. The purpose of AI is to decrease the burden of repetitive…

Details

A New Approach at Conducting Post-Market Drug Safety Surveillance

eVERABy veracuity March 4, 2020

Veracuity Blog A New Approach at Conducting Post-Market Drug Safety Surveillance The early foundation of Veracuity’s platform eVERA tracks back to a series of works by Dr Veronika Valdova in collaboration with Dr Jonathan Fishbein. The works describe the shortcomings of the current post-market drug safety surveillance and outline ways the process can be optimized.…

Details

The opioid epidemic in drug safety reporting systems

UncategorizedBy veracuity February 4, 2020

Veracuity Blog The opioid epidemic in drug safety reporting systems Last week, the founder of Insys Therapeutics, John Kapoor (76), was sentenced to 66 months in prison for orchestrating a scheme to bribe physicians to prescribe Subsys, a highly addictive form of fentanyl, to patients who did not need this drug. Five corporate executives, including…

Details